TAGS: Sustainability / Natural Cosmetics Perfumes & Fragrances
Solvay announces an investment in SUANFARMA’s Cipan manufacturing site located in Lisbon, Portugal to develop its biotechnological capabilities and support the development of natural ingredients and boost natural vanillin growth.
It will enable Solvay to grow its capabilities for natural ingredients in Food, Flavors & Fragrances industries.
New Business Opportunities Enabled by Biotechnology
This aligns with Solvay’s newest growth platform “Renewable materials and biotechnology” which aims to meet the growing demand for sustainable solutions by increasing the share of renewable carbon in Solvay’s product offering and developing new business opportunities enabled by biotechnology.
This transaction, to be completed by mid-2023, is the first step of a long-term strategic alliance with SUANFARMA, held by ArchiMed, one of the leading global life science investment firms.
“
Solvay is already a leader in natural ingredients - now with this exciting investment, we will pave the way for further growth in Naturals. The investment is in line with our newly formed Renewable Materials and Biotechnology growth platform and will boost our ability to meet our customers' long-term needs and enable the switch to bio-sourced and natural ingredients,” said An Nuyttens, president of Aroma & Silica Global Business Units.
“
This first step of our collaboration with SUANFARMA provides access to efficiently raise our existing capacities on natural ingredients, including our flagship natural vanillin, Rhovanil® Natural CW. Produced through a natural fermentation process with the highest standards of quality control and traceability, Rhovanil® Natural is manufactured in Europe and offers reliable and future-proof supply to our customers,” added Jo Grosemans, director of Solvay Natural Growth.
Explore Bio-based Range from Solvay
Source: Solvay
